Envestnet Asset Management Inc Stealth Bio Therapeutics Corp Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.2 - $0.32 $1,080 - $1,729
5,404 Added 30.28%
23,248 $7,000
Q2 2022

Aug 03, 2022
BUY
$0.18 - $0.71 $651 - $2,569
3,619 Added 25.44%
17,844 $5,000
Q1 2022

May 04, 2022
BUY
$0.49 - $0.9 $885 - $1,627
1,808 Added 14.56%
14,225 $10,000
Q4 2021

Feb 04, 2022
BUY
$0.76 - $1.48 $9,436 - $18,377
12,417 New
12,417 $10,000

Others Institutions Holding MITO

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About Stealth BioTherapeutics Corp

MITO Quotes by TradingView
  • Ticker MITO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,548,600
  • Description
  • Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...
More about MITO
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email